E3 ligases RNF43 and ZNRF3 display differential specificity for endocytosis of Frizzled receptors.

Autor:	Bugter JM; Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands., van Kerkhof P; Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands., Jordens I; Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands., Janssen E; Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands., Tran Ngoc Minh T; Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands., Iglesias van Montfort D; Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands., Jamieson C; Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands., Maurice MM; Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands m.m.maurice@umcutrecht.nl.
Jazyk:	angličtina
Zdroj:	Life science alliance [Life Sci Alliance] 2024 Jul 05; Vol. 7 (9). Date of Electronic Publication: 2024 Jul 05 (Print Publication: 2024).
DOI:	10.26508/lsa.202402575
Abstrakt:	The transmembrane E3 ligases RNF43 and ZNRF3 perform key tumour suppressor roles by inducing endocytosis of members of the Frizzled (FZD) family, the primary receptors for WNT. Loss-of-function mutations in RNF43 and ZNRF3 mediate FZD stabilisation and a WNT-hypersensitive growth state in various cancer types. Strikingly, RNF43 and ZNRF3 mutations are differentially distributed across cancer types, raising questions about their functional redundancy. Here, we compare the efficacy of RNF43 and ZNRF3 of targeting different FZDs for endocytosis. We find that RNF43 preferentially down-regulates FZD1/FZD5/FZD7, whereas ZNRF3 displays a preference towards FZD6. We show that the RNF43 transmembrane domain (TMD) is a key molecular determinant for inducing FZD5 endocytosis. Furthermore, a TMD swap between RNF43 and ZNRF3 re-directs their preference for FZD5 down-regulation. We conclude that RNF43 and ZNRF3 preferentially down-regulate specific FZDs, in part by a TMD-dependent mechanism. In accordance, tissue-specific expression patterns of FZD homologues correlate with the incidence of RNF43 or ZNRF3 cancer mutations in those tissues. Consequently, our data point to druggable vulnerabilities of specific FZD receptors in RNF43 - or ZNRF3 -mutant human cancers. (© 2024 Bugter et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu